This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1999 Feb 20;353(9153):604-5.

doi: 10.1016/S0140-6736(98)00361-4.

Which drug for treatment of hypertension?

J Cutler¹

Affiliations

PMID: 10030320
DOI: 10.1016/S0140-6736(98)00361-4

Comment

Which drug for treatment of hypertension?

J Cutler. Lancet. 1999.

. 1999 Feb 20;353(9153):604-5.

doi: 10.1016/S0140-6736(98)00361-4.

Author

J Cutler¹

Affiliation

¹ Clinical Applications and Preventive Program, National Heart Lung and Blood Institute, Bethesda, MD 20892, USA.

PMID: 10030320
DOI: 10.1016/S0140-6736(98)00361-4

No abstract available

PubMed Disclaimer

Comment on

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.
Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, Luomanmäki K, Dahlöf B, de Faire U, Mörlin C, Karlberg BE, Wester PO, Björck JE. Hansson L, et al. Lancet. 1999 Feb 20;353(9153):611-6. doi: 10.1016/s0140-6736(98)05012-0. Lancet. 1999. PMID: 10030325 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information